These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31840517)

  • 1. Self-Propelled Gemini-like LMWH-Scaffold Nanodrugs for Overall Tumor Microenvironment Manipulation via Macrophage Reprogramming and Vessel Normalization.
    Xu C; Yang S; Jiang Z; Zhou J; Yao J
    Nano Lett; 2020 Jan; 20(1):372-383. PubMed ID: 31840517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinforcing vascular normalization therapy with a bi-directional nano-system to achieve therapeutic-friendly tumor microenvironment.
    Deng Y; Jiang Z; Jin Y; Qiao J; Yang S; Xiong H; Yao J
    J Control Release; 2021 Dec; 340():87-101. PubMed ID: 34662587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction to "Self-Propelled Gemini-like LMWH-Scaffold Nanodrugs for Overall Tumor Microenvironment Manipulation via Macrophage Reprogramming and Vessel Normalization".
    Xu C; Yang S; Jiang Z; Zhou J; Yao J
    Nano Lett; 2021 Jan; 21(1):889. PubMed ID: 33336578
    [No Abstract]   [Full Text] [Related]  

  • 4. pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release.
    Xiong H; Wu Y; Jiang Z; Zhou J; Yang M; Yao J
    J Colloid Interface Sci; 2019 Feb; 536():135-148. PubMed ID: 30366179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment.
    Mei L; Liu Y; Xia C; Zhou Y; Zhang Z; He Q
    Mol Pharm; 2017 Feb; 14(2):513-522. PubMed ID: 28026951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis.
    Chen Y; Peng J; Han M; Omar M; Hu D; Ke X; Lu N
    J Drug Target; 2015 May; 23(4):335-46. PubMed ID: 25541466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment.
    Licarete E; Rauca VF; Luput L; Drotar D; Stejerean I; Patras L; Dume B; Toma VA; Porfire A; Gherman C; Sesarman A; Banciu M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy.
    Li Y; Wu Y; Huang L; Miao L; Zhou J; Satterlee AB; Yao J
    J Control Release; 2016 Apr; 228():107-119. PubMed ID: 26941036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
    Licarete E; Rauca VF; Luput L; Patras L; Sesarman A; Banciu M
    Oncol Rep; 2019 Dec; 42(6):2694-2705. PubMed ID: 31578578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-reduction antiangiogenic curcumin-low molecular weight heparin nanodrugs for enhanced combinational antitumor therapy.
    Xiao Y; Xu C; Xiong H; Du S; Zhou J; Yin L; Yao J
    Eur J Pharm Sci; 2018 Jul; 119():121-134. PubMed ID: 29635010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic activity and antitumor efficacy of amphiphilic twin drug from ursolic acid and low molecular weight heparin.
    Cheng W; Dahmani FZ; Zhang J; Xiong H; Wu Y; Yin L; Zhou J; Yao J
    Nanotechnology; 2017 Feb; 28(7):075102. PubMed ID: 28091396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
    Jarosz-Biej M; Kamińska N; Matuszczak S; Cichoń T; Pamuła-Piłat J; Czapla J; Smolarczyk R; Skwarzyńska D; Kulik K; Szala S
    PLoS One; 2018; 13(1):e0191012. PubMed ID: 29320562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles.
    Zhang T; Xiong H; Dahmani FZ; Sun L; Li Y; Yao L; Zhou J; Yao J
    Nanotechnology; 2015 Apr; 26(14):145101. PubMed ID: 25771790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells.
    Long Y; Lu Z; Xu S; Li M; Wang X; Zhang Z; He Q
    Nano Lett; 2020 Apr; 20(4):2219-2229. PubMed ID: 31823615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
    Du H; Liu M; Yu A; Ji J; Zhai G
    Int J Pharm; 2017 May; 523(1):427-438. PubMed ID: 28359815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy.
    Sun H; Cao D; Wu H; Liu H; Ke X; Ci T
    Int J Biol Macromol; 2018 Jun; 112():343-355. PubMed ID: 29409771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Microenvironment-Responsive Ultrasmall Nanodrug Generators with Enhanced Tumor Delivery and Penetration.
    Zhang P; Wang J; Chen H; Zhao L; Chen B; Chu C; Liu H; Qin Z; Liu J; Tan Y; Chen X; Liu G
    J Am Chem Soc; 2018 Nov; 140(44):14980-14989. PubMed ID: 30359020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin.
    Mousa SA; Linhardt R; Francis JL; Amirkhosravi A
    Thromb Haemost; 2006 Dec; 96(6):816-21. PubMed ID: 17139378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis.
    Huang S; Shao K; Liu Y; Kuang Y; Li J; An S; Guo Y; Ma H; Jiang C
    ACS Nano; 2013 Mar; 7(3):2860-71. PubMed ID: 23451830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice.
    Zhang B; Jin K; Jiang T; Wang L; Shen S; Luo Z; Tuo Y; Liu X; Hu Y; Pang Z
    Sci Rep; 2017 Aug; 7(1):10071. PubMed ID: 28855534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.